In diabetic nephropathy, where COL-IV is a major deposited collagen, Smad3 binds to promoter regions of COL4A1A2, COL4A3A4, and COL4A5, a process inhibited by C-peptide [55]. Here, COL4A5 is linked to diabetic kidney disease.